1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 16,400 | 16,450 | 17:23 | |
| 16,238 | 16,600 | 17:25 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| MINIMED GROUP Aktie jetzt für 0€ handeln | |||||
| 22.07. | MiniMed says Flex insulin pump is now available through Medicare | - | MassDevice | ||
| 08.07. | Benchmark reiterates MiniMed Group stock rating on model update | 2 | Investing.com | ||
| 29.06. | MiniMed Group, Inc. - 10-K, Annual Report | 3 | SEC Filings | ||
| 29.06. | MiniMed adds Alcon CEO, Medtronic exec to board of directors | 9 | MassDevice | ||
| 29.06. | MiniMed Group, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 29.06. | MiniMed appoints Alcon CEO David Endicott and Linnea Burman to its Board of Directors | 738 | PR Newswire | David Endicott, Chief Executive Officer of Alcon, brings global healthcare leadership and public company experience; Linnea Burman adds MedTech operating depth NORTHRIDGE, Calif., June... ► Artikel lesen | |
| 24.06. | MiniMed Launches Abbott's Instinct Sensors Across European Markets | 9 | Zacks | ||
| 23.06. | MiniMed launches Instinct sensors made by Abbott with insulin delivery tech in Europe | 13 | MassDevice | ||
| 23.06. | MiniMed launches Instinct sensors in Europe giving people with diabetes more sensor choice with the same proven outcomes | 1.039 | PR Newswire | MiniMed automated insulin delivery and smart MDI systems can now be paired with Instinct and Instinct Go, made by Abbott, the smallest, longest-wear sensors in the company's portfolioNORTHRIDGE... ► Artikel lesen | |
| 17.06. | MiniMed begins miniature Flex pump rollout in US | 2 | MassDevice | ||
| 12.06. | Benchmark reiterates MiniMed Group stock rating on product launches | 1 | Investing.com | ||
| 04.06. | Benchmark reiterates Buy on MiniMed stock, cites product launches | 2 | Investing.com | ||
| 04.06. | Piper Sandler bestätigt "Neutral"-Rating für MiniMed mit Kursziel von 16 $ | 1 | Investing.com Deutsch | ||
| 04.06. | Piper Sandler reiterates Neutral rating on MiniMed stock at $16 | 1 | Investing.com | ||
| 03.06. | MiniMed Group Shares Surge 14% Over Strong Revenue Growth In Q4 | 1 | RTTNews | ||
| 03.06. | Navitas Semiconductor, Abivax, MiniMed And Other Big Stocks Moving Higher On Wednesday | 30 | Benzinga.com | ||
| 03.06. | MiniMed meldet starkes Wachstum in Q4 2026 - Aktie legt zu | 16 | Investing.com Deutsch | ||
| 03.06. | Full Transcript: Minimed Group Q4 2026 Earnings Call | 13 | Benzinga.com | ||
| 03.06. | MiniMed adds Abbott dual glucose-ketone sensor to portfolio, posts Q4 sales beat | 2 | MassDevice | ||
| 03.06. | Minimed Reports Wider Q4 Loss Despite Higher Revenue, Shares Rise In Pre-market | 3 | RTTNews |
1 2 3 4 5 Weiter >>
89 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 39,010 | -0,26 % | DAX-Check LIVE: Aixtron, Aumovio, Fuchs Vz., Hensoldt, Puma, Siemens Healthineers, Siltronic | Angesichts der gestiegenen Inflation und der weiterhin unsicheren Lage im Iran ist die Stimmung am deutschen Aktienmarkt verhalten geblieben. Am späten Nachmittag hellte sie sich jedoch etwas auf. Der... ► Artikel lesen | |
| HEALWELL AI | 0,411 | +0,98 % | HEALWELL AI: HEALWELL AI Announces Voting Results of 2026 AGSM | Toronto, Ontario--(Newsfile Corp. - June 26, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative... ► Artikel lesen | |
| LIFEWARD | 7,210 | +2,71 % | Lifeward Ltd.: Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing | HUDSON, Mass. and YOKNEAM ILLIT, Israel, July 07, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a diversified biomedical innovation company with a portfolio... ► Artikel lesen | |
| IMUNON | 1,330 | -3,62 % | Imunon, Inc.: IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer | Enrollment momentum exceeding expectations is based on highly promising survival (OS) data and well tolerated safety profile demonstrated in the Company's large, randomized Phase II study, OVATION... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 52,50 | +15,64 % | Inspire Medical Systems, Inc. Announces Second Quarter 2026 Financial Results, Raised 2026 Guidance, and Strategic Growth Plan | Generated second quarter revenue of $200.6 millionSecond quarter diluted EPS of $0.01; adjusted diluted EPS of $0.14Second quarter operating cash flow of $23.2 millionAnnounced strategic growth plan... ► Artikel lesen | |
| INSPIREMD | 0,595 | +0,85 % | InspireMD Inc.: InspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and Marketing | MIAMI, July 30, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) ("InspireMD" or the "Company"), developer of the CGuard Prime carotid stent system for the prevention of stroke, today announced... ► Artikel lesen | |
| GT BIOPHARMA | 0,323 | +4,63 % | GT Biopharma, Inc.: GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors | GTB-5550 is now the 3rd TriKE- to enter the clinic and an expansion into a broader solid tumor opportunity, with the Phase 1 trial likely to focus on prostate cancer patients during the dose escalation... ► Artikel lesen | |
| MYOMO | 0,866 | -4,63 % | MYOMO, INC. - 8-K, Current Report | ||
| INOGEN | 5,750 | -1,71 % | Inogen Inc - S-8, Securities to be offered to employees in employee benefit plans | ||
| MEDLINE | 36,200 | 0,00 % | DENTSPLY SIRONA Inc.: Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship | CHARLOTTE, N.C., July 28, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona, the world's largest diversified manufacturer of professional dental products and technologies, today announced an expansion of its... ► Artikel lesen | |
| INTELLIGENT BIO SOLUTIONS | 1,780 | -1,11 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Completes Interference Study Examining the Impact of Everyday Substances on Intelligent Fingerprinting System | NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen | |
| OMADA HEALTH | 17,600 | -1,68 % | Omada Health, Inc.: Omada Health Joins Lilly Employer Connect, Expanding Its Access Pathways for GLP-1 Care as Patients Seek More Lifestyle Support | SAN FRANCISCO, May 07, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA) announced it will serve as an independent program administrator in Eli Lilly and Company's Employer Connect program. Omada... ► Artikel lesen | |
| INCANNEX HEALTHCARE | 3,030 | +3,95 % | Incannex Healthcare: Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea | First clinical sites approved and actively screening potential participantsRepresents another major milestone in the advancement of IHL-42X towards Phase III developmentIHL-42X has received FDA Fast... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | - | - | Lexaria Bioscience Corp.: Lexaria Announces Effective Date for Reverse Stock Split | KELOWNA, BC / ACCESS Newswire / July 30, 2026 / Lexaria Bioscience Corp. (Nasdaq:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that it intends to effect... ► Artikel lesen | |
| GLUCOTRACK | 0,401 | -3,37 % | Glucotrack, Inc.; Lokahi Therapeutics: Glucotrack and Lokahi Therapeutics Complete Strategic Business Combination, Establishing Lokahi-Controlled Public Platform | RUTHERFORD, N.J. and LA JOLLA, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) today announced the completion of its strategic business combination with Lokahi Therapeutics... ► Artikel lesen |
Das Unternehmen MINIMED GROUP INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,366 (+2,21 %) liegt der Kurs bei 16,948 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MINIMED GROUP INC finden Sie auf Wallstreet Online.